16712-55-3 Usage
Derivative
Indole derivative
Functional Group
Methoxy group ( \textCH3\textO) attached to the carbon 3 position of the indole ring
Usage
Organic Synthesis: Commonly used as a building block in organic synthesis
Pharmaceutical Research: Used in pharmaceutical research for drug development
Pharmacological Properties
Serotonin Reuptake Inhibition: Investigated for its potential as a serotonin reuptake inhibitor
Research Significance
Drug Synthesis: Investigated for its potential in the synthesis of various drug molecules
Scientific Interest
Research Studies: Shown promise in various research studies
Continued Interest: Continues to be of interest in the scientific community
Check Digit Verification of cas no
The CAS Registry Mumber 16712-55-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,7,1 and 2 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 16712-55:
(7*1)+(6*6)+(5*7)+(4*1)+(3*2)+(2*5)+(1*5)=103
103 % 10 = 3
So 16712-55-3 is a valid CAS Registry Number.
16712-55-3Relevant articles and documents
INTRODUCTION OF NUCLEOPHILES OR ETHYL GROUP TO THE INDOLE NUCLEUS THROUGH NUCLEOPHILIC SUBSTITUTION AND/OR RADICAL REACTIONS OF 1-METHOXYINDOLE-3- AND -2-CARBOXALDEHYDE
Yamada, Fumio,Fukui, Yoshikazu,Shinmyo, Daisuke,Somei, Masanori
, p. 99 - 104 (2007/10/02)
1-Methoxyindole-3- and -2-carboxaldehyde were found to undergo nucleophilic substitution and radical reactions resulting in the introduction of nucleophiles and/or ethyl group at the 2- or 3-position.
A NEW CARBON-CARBON BOND FORMING REACTION IN INDOLE CHEMISTRY. C3-ARYLATION AND ALKYLATION WITH PHENYL (β-INDOLYL)IODONIUM TRIFLUOROACETATE
Moriarty, Robert M.,Ku, Y. Y.,Sultana, M.,Tuncay, Atilla
, p. 3071 - 3074 (2007/10/02)
Phenyl(β-indolyl)iodonium trifuoroacetate was reacted with various alkyl and aryllithiums (CH3, n-C4H9, C3H5, C6H5) in BF3Et2O/THF to yield C3-alkylation and arylation of the indole nucleus with reductive elimination of iodobenzene.